Rani Therapeutics: HC Wainwright Raises PT to $11, Reiterates Buy Rating

viernes, 27 de marzo de 2026, 7:01 am ET1 min de lectura
RANI--

Rani Therapeutics: HC Wainwright Raises PT to $11, Reiterates Buy Rating

Rani Therapeutics: HC Wainwright Raises PT to $11, Reiterates Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios